Urogen Pharma Ltd. announced that Mark Schoenberg, M.D., has been named Chief Medical Officer of UroGen, having previously served the Company as Medical Director. In addition, the Company announced the appointment of Elyse Seltzer, M.D., as UroGen’s Senior Vice President of Clinical Development. The Company also announced that Chaim Hurvitz has resigned from the Company’s board of directors. Prior to joining UroGen, Dr. Seltzer served as Chief Medical Officer of Nabriva Therapeutics.